## EXPD: Expeditors International of Was - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.6% below STRENGTH zone (4.0-10.0%); PEG 5.29 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($145.30)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Thrivent Financial for Lutherans Sells 72,654 Shares of Expeditors International of Washington, Inc. $EXPD**
- Source: MarketBeat | 20251215T120822 | Somewhat-Bearish | Relevance: 100%
- Thrivent Financial for Lutherans has reduced its stake in Expeditors International of Washington, Inc. (NASDAQ:EXPD) by 10.2%, selling 72,654 shares, though it still owns 637,173 shares valued at approximately $72.8 million. The company recently declared a $0.77 dividend, payable on December 15th, with an unusually high reported dividend yield of 105.0%. Despite institutional investors owning 94.02% of the company, insiders have been selling shares, and analysts currently have a "Reduce" rating with an average price target of $128.20.

**2. Expeditors International stock hits all-time high at 151.7 USD By Investing.com**
- Source: Investing.com South Africa | 20251211T164601 | Bullish | Relevance: 100%
- Expeditors International of Washington Inc. (EXPD) stock reached an all-time high of $151.7 USD, reflecting significant investor confidence and robust performance for the logistics company. The stock has seen substantial gains, including 27.24% over the past year and 38.3% year-to-date, supported by a strong financial position with more cash than debt and 33 consecutive years of dividend payments. Analysts have revised earnings upwards, and recent upgrades from UBS and BofA Securities further underscore positive outlooks for the company.

**3. Expeditors International Soars to All-Time Stock High Amidst Robust Performance and Strategic Acumen**
- Source: Markets Financial Content | 20251211T161324 | Bullish | Relevance: 100%
- Expeditors International of Washington Inc. (NASDAQ: EXPD) reached an unprecedented all-time high stock price of $151.70 USD on December 11, 2025, reflecting strong investor confidence and strategic acumen in navigating global supply chains. This performance highlights the company's asset-light model, technological investments in AI, and customer-centric approach, solidifying its position as a market leader. While facing short-term headwinds, Expeditors is poised for continued growth through e-commerce expansion, supply chain resilience solutions, and sustained investment in technology.

**4. Expeditors International of Washington, Inc. $EXPD Shares Bought by Qube Research & Technologies Ltd**
- Source: MarketBeat | 20251212T120808 | Neutral | Relevance: 100%
- Qube Research & Technologies Ltd increased its stake in Expeditors International of Washington, Inc. by 4.1% in Q2 2025, now holding 683,313 shares valued at approximately $78.07 million. The company recently announced a $0.77 per share dividend payable on December 15th, and analysts currently have a consensus "Reduce" rating with an average target price significantly lower than its current trading price.

**5. State Street Corp Trims Stock Position in Expeditors International of Washington, Inc. $EXPD**
- Source: MarketBeat | 20251212T120807 | Somewhat-Bearish | Relevance: 100%
- State Street Corp reduced its stake in Expeditors International of Washington, Inc. by 2.3% during the second quarter, selling 173,727 shares but still owning 5.40% of the company. Analysts have a consensus "Reduce" rating for EXPD with an average price target below its current trading price, while the company recently announced a dividend payment. Additionally, two insiders, including the VP and a director, sold shares of EXPD in early November.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $95 | $90 | +6% |
| 2025-11-17 | UBS | $166 | $138 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Underweight |
| 2025-11-17 | UBS | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-0.9%)
- Blackrock Inc.: 9.2% (-10.1%)
- State Street Corpora: 5.8% (+5.1%)
- First Eagle Investme: 4.7% (+0.0%)
- LOOMIS SAYLES & CO L: 4.3% (+1.6%)

### Key Risks

1. Valuation stretched: PEG 5.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 5.29 signals overvaluation risk, limited margin of safety. Forward P/E 25.4x stretched relative to 2% growth. Quality metrics strong (ROE 36%, ROA 14%). Analyst sentiment positive (2 raises, avg +13%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.6B |
| Beta | 1.14 |
| 52W Range | $100.47 - $154.47 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.29 |
| Forward P/E | 25.4 |
| Current P/E | 25.8 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.9% to 3.6% (+2.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >4.0% for momentum thesis). MRS_5 at 2.3% confirms short-term momentum alignment. AM_20 at 3.9% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.56% (CS: 66) | Neutral |
| RSI_14 | 68.2 | Neutral |
| MACD Histogram | -0.18 | Bearish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.141x | Above |
| vs SMA200 | 1.262x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $151.76
- **Stop Loss:** $145.30 (4.3% risk)
- **Target:** $158.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 185
- **Position Value:** $28,075.60
- **Portfolio %:** 28.08%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-24 (Est: $1.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.39 | $1.64 | +18.1% |
| 2025Q2 | $1.24 | $1.34 | +7.9% |
| 2025Q1 | $1.35 | $1.47 | +9.1% |
| 2024Q4 | $1.44 | $1.68 | +16.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*